Studies have also shown that BRCA1 mutation carriers are not at high risk for CRC (Cullinane et al., 2020) and that NOVA1 is expressed at higher levels in CRC cell lines (Hong et al., 2019). This evidence concerns the gene BRCA1 and colorectal carcinoma.